Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
about
A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemiaSignificance of neuropilin-1 expression in acute myeloid leukemia.Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia.Expression of aberrant antigens in hematological malignancies: A single center experience.
P2860
Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
@en
type
label
Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
@en
prefLabel
Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
@en
P2093
P2860
P1476
Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
@en
P2093
Brian A Webber
Melissa M Cushing
Shiyong Li
P2860
P304
P577
2008-01-01T00:00:00Z